Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer.
de Boo LW, Jóźwiak K, Ter Hoeve ND, van Diest PJ, Opdam M, Wang Y, Schmidt MK, de Jong V, Kleiterp S, Cornelissen S, Baars D, Koornstra RHT, Kerver ED, van Dalen T, Bins AD, Beeker A, van den Heiligenberg SM, de Jong PC, Bakker SD, Rietbroek RC, Konings IR, Blankenburgh R, Bijlsma RM, Imholz ALT, Stathonikos N, Vreuls W, Sanders J, Rosenberg EH, Koop EA, Varga Z, van Deurzen CHM, Mooyaart AL, Córdoba A, Groen E, Bart J, Willems SM, Zolota V, Wesseling J, Sapino A, Chmielik E, Ryska A, Broeks A, Voogd AC, van der Wall E, Siesling S, Salgado R, Dackus GMHE, Hauptmann M, Kok M, Linn SC. de Boo LW, et al. Among authors: van dalen t. ESMO Open. 2024 Mar;9(3):102923. doi: 10.1016/j.esmoop.2024.102923. Epub 2024 Mar 6. ESMO Open. 2024. PMID: 38452438 Free PMC article.
Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.
van Nes JG, Seynaeve C, Maartense E, Roumen RM, de Jong RS, Beex LV, Meershoek-Klein Kranenbarg WM, Putter H, Nortier JW, van de Velde CJ; Cooperating investigators of the Dutch TEAM trial. van Nes JG, et al. Ann Oncol. 2010 May;21(5):974-82. doi: 10.1093/annonc/mdp419. Epub 2009 Oct 29. Ann Oncol. 2010. PMID: 19875752 Free article. Clinical Trial.
[Gene expression classifiers in the prognosis of breast cancer].
Drukker CA, Schmidt MK, van Dalen T, van der Hoeven JJ, Linn SC, Rutgers EJ. Drukker CA, et al. Among authors: van der hoeven jj, van dalen t. Ned Tijdschr Geneeskd. 2014;158:A7001. Ned Tijdschr Geneeskd. 2014. PMID: 24780571 Review. Dutch.
Contemporary Locoregional Recurrence Rates in Young Patients With Early-Stage Breast Cancer.
Aalders KC, Postma EL, Strobbe LJ, van der Heiden-van der Loo M, Sonke GS, Boersma LJ, van Diest PJ, Siesling S, van Dalen T. Aalders KC, et al. Among authors: van der heiden van der loo m, van diest pj, van dalen t. J Clin Oncol. 2016 Jun 20;34(18):2107-14. doi: 10.1200/JCO.2015.64.3536. Epub 2016 Mar 14. J Clin Oncol. 2016. PMID: 26976422
Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers.
Lobbes MB, Vriens IJ, van Bommel AC, Nieuwenhuijzen GA, Smidt ML, Boersma LJ, van Dalen T, Smorenburg C, Struikmans H, Siesling S, Voogd AC, Tjan-Heijnen VC. Lobbes MB, et al. Among authors: van bommel ac, van dalen t. Breast Cancer Res Treat. 2017 Apr;162(2):353-364. doi: 10.1007/s10549-017-4117-8. Epub 2017 Jan 28. Breast Cancer Res Treat. 2017. PMID: 28132393 Free PMC article.
Breast magnetic resonance imaging use in patients undergoing neoadjuvant chemotherapy is associated with less mastectomies in large ductal cancers but not in lobular cancers.
Vriens IJH, Keymeulen K, Lobbes MBI, van Bommel ACM, Nieuwenhuijzen GAP, Smidt ML, Boersma LJ, van Dalen T, Smorenburg CH, Struikmans H, Siesling S, Voogd AC, Tjan-Heijnen VCG; National Breast Cancer Organization of the Netherlands – Breast Cancer Audit Scientific Committee (NBCA). Vriens IJH, et al. Among authors: van bommel acm, van dalen t. Eur J Cancer. 2017 Aug;81:74-80. doi: 10.1016/j.ejca.2017.05.012. Epub 2017 Jun 12. Eur J Cancer. 2017. PMID: 28618304
Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor-Positive Early Breast Cancer: Results of a Prospective Cohort Study.
Kuijer A, Straver M, den Dekker B, van Bommel ACM, Elias SG, Smorenburg CH, Wesseling J, Linn SC, Rutgers EJT, Siesling S, van Dalen T. Kuijer A, et al. Among authors: van bommel acm, van dalen t. J Clin Oncol. 2017 Aug 20;35(24):2814-2819. doi: 10.1200/JCO.2016.70.3959. Epub 2017 Mar 13. J Clin Oncol. 2017. PMID: 28813638
183 results